Clever Leaves Teams Up With SOMAÍ Pharma., Completes First CBD Extract Shipments To Portugal
Portfolio Pulse from Vuk Zdinjak
Clever Leaves Holdings Inc. (NASDAQ:CLVR) (NASDAQ:CLVRW) has entered into a five-year agreement with SOMAÍ Pharmaceuticals to supply EU-GMP certified CBD extracts from Colombia to its operations in Portugal. The first shipments have been completed, and Clever Leaves will continue to supply pharmaceutical-grade APIs and CBD extracts for patients across Europe.
May 25, 2023 | 1:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Clever Leaves enters a 5-year agreement with SOMAÍ Pharmaceuticals to supply EU-GMP certified CBD extracts from Colombia to Portugal, expanding its presence in Europe.
The partnership with SOMAÍ Pharmaceuticals expands Clever Leaves' presence in Europe and increases its potential customer base. This is likely to have a positive impact on the company's revenues and growth prospects in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Clever Leaves Holdings Inc. (CLVRW) enters a 5-year agreement with SOMAÍ Pharmaceuticals to supply EU-GMP certified CBD extracts from Colombia to Portugal, expanding its presence in Europe.
The partnership with SOMAÍ Pharmaceuticals expands Clever Leaves' presence in Europe and increases its potential customer base. This is likely to have a positive impact on the company's revenues and growth prospects in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100